Sign in

CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-1/A Offering Registration Statement
  6. CERT Other Certification
  7. S-1/A Offering Registration Statement
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. 8-A12B Other Registration of Securities
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-1 Offering Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRS/A Other Draft Registration Statement
  20. DRSLTR Other Correspondence Related to Draft Registration Statement

Page 21 of 22 · 422 filings